切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - PP2A/Nkd interaction - EGFR - Heme oxygenase - Voltage-gated Potassium (KV) Channels

30件产品中的 1-10

页面
每页
清除全部
  1. EGF816
    B5889 EGF816
     2 Citation
    中文名: 那扎替尼
    Target: EGFR
    Summary: EGFR突变选择性抑制剂
      Soluble in DMSO
  2. AZ5104
    B5836 AZ5104
    Target: EGFR
    Summary: EGFR抑制剂
      ≥16.95 mg/mL
      insoluble in H2O
  3. IQ 1
    B7700 IQ 1
    Target: Stem Cell Differentiation|PP2A/Nkd interaction
    Summary: 维持胚胎干细胞(ESC)的多能性
      ≥37.5 mg/mL
      insoluble in H2O
  4. Psora 4
    B7659 Psora 4
     1 Citation
    Target: Voltage-gated Potassium (KV) Channels
    Summary: Kv1.3阻断剂
      ≥15.75 mg/mL
      insoluble in H2O
  5. Zinc protoporphyrin IX
    B6431 Zinc protoporphyrin IX
     2 Citation
    中文名: 锌原卟啉
    Target: Guanylyl Cyclases|Heme oxygenase
    Summary: 血红素加氧酶抑制剂
      ≥20 mg/mL
      insoluble in H2O
  6. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  7. AZD-9291
    B1104 AZD-9291
     1 Citation
    中文名: 奥希替尼
    Target: EGFR
    Summary: 突变型EGFR抑制剂。
      ≥24.98 mg/mL
      insoluble in H2O
  8. Cisapride
    B1198 Cisapride
    Target: Voltage-gated Potassium (KV) Channels|5-HT4 Receptor
    Summary: 5-HT4受体激动剂
      ≥23.3 mg/mL
      insoluble in H2O
  9. Vandetanib (ZD6474)
    A8555 Vandetanib (ZD6474)
    中文名: 凡德他尼
    Target: VEGFR|EGFR
    Summary: VEGFR2/EGFR拮抗剂
      ≥11.88 mg/mL
      insoluble in H2O
  10. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O

30件产品中的 1-10

页面
每页